BioTelemetry, Inc. (NASDAQ:BEAT) Files An 8-K Regulation FD Disclosure

BioTelemetry, Inc. (NASDAQ:BEAT) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.

Story continues below

On March 4, 2019, BioTelemetry, Inc. issued a press release announcing the closing of the previously announced acquisition of Geneva Healthcare, Inc. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

ExhibitNumber

ExhibitTitle

Press release dated March 4, 2019

BIOTELEMETRY, INC. Exhibit
EX-99.1 2 beat34198kexhibit991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1BioTelemetry,…
To view the full exhibit click here

An ad to help with our costs